how common is gastroparesis with semaglutide 🧬 GLP-1s and Gastroparesis: What You Need to Know, GLP-1 receptor agonists (like and tirzepatide) have revolutionized weight management and type 2 diabetes care. But as use has Managing Gastroparesis and SIBO associated

Use of generic GLP-1 medications is expected to increase by 30% by 2025, according to the HealthVerity Blog, further affecting formulary preferences and substitution frequency

#Pharmacovigilance #MedDRA #DrugSafety #OpenVigil #FAERS #MedicationErrors #DataVisualization To view or add a comment, sign in As pharmacogenomics moves from bench to bedside, the scope of druggene evidence has exploded

Listen To Your Body Fatigue, dizziness, or mood swings are signs to pause and reassess

Maybe it is Botox, filler, laser hair removal, a weight loss plan, or something you have been thinking about for months

In clinical trials of Wegovy (a semaglutide medication), participants lost an average of 15% of their body weight (approximately 33 pounds, though individual results varied) within 68 weeks